FDA OKs Viasys spirometry device

Wednesday, January 31, 2007

CONSHOHOCKEN, Pa. - The U.S. Food and Drug Administration has given Viasys Respiratory permission to market its PulmoLife spirometry screener. PulmoLife uses spirometry to measure lung function. According to the National Institutes of Health, "Spirometry is the most sensitive and commonly used test of lung functions. It can detect COPD long before you have significant symptoms." Early detection of decreased lung function by the PulmoLife device may help a smoker realize the damage smoking can cause and encourage them to seek smoking cessation and medical treatment, Viasys stated in a release.